Journal
JOURNAL OF NEUROSURGERY
Volume 111, Issue 2, Pages 343-350Publisher
AMER ASSOC NEUROLOGICAL SURGEONS
DOI: 10.3171/2008.11.JNS08797
Keywords
acute pain; analgesia; craniotomy; neurosurgery; opioids; patient-controlled analgesia
Categories
Funding
- Jacob and Hilda Blaustein Foundation (Yaster)
- National Institutes of Health [NS041865]
- Richard J. Traystman endowed chair
Ask authors/readers for more resources
Object. Opioid administration following major intracranial surgery is often limited by a presumed lack of need and a concern that opioids will adversely affect postoperative Outcome and interfere with the neurological examination. Nevertheless, evidence is accumulating that these patients suffer moderate to severe postoperative pain and that this pain is often undertreated. The authors hypothesized that intravenous patient-controlled analgesia (PCA) would safely and more effectively treat postoperative supratentorial craniotomy pain than conventional as needed (PRN) therapy. Methods. Following a standardized Course of general anesthesia, adult patients who underwent elective supratentorial intracranial surgery were randomized in the neurosciences intensive care unit to receive either PRN intravenous fentanyl 25-50 mu g every 30 minutes or PCA intravenous fentanyl 0.5 mu g/kg every 15 minutes (maximum 4 doses/hour). The authors measured pain (self-reported scale score [0-10]), sedation (Ramsay Sedation Scale score), Glasgow Coma Scale score, fentanyl use, and major adverse events (excessive sedation, respiratory depression, pruritus, nausea, or vomiting) hourly. Results. Sixty-four patients with a mean age of 48 years (range 22-77 years) were randomized to intravenous PCA (29 patients) or PRN fentanyl (35 patients) groups. There were no statistically significant demographic differences between the 2 groups. Patients receiving intravenous PCA had significantly lower pain scores than those receiving intravenous PRN fentanyl (2.53 +/- 1.96 vs 3.62 +/- 2.11 [p = 0.039]) and received significantly more fentanyl than the PRN group (44.1 +/- 34.5 vs 23.6 +/- 23.7 mu g/hour [p = 0.007]). There were no differences between the 2 groups regarding the number of patients with adverse events. Conclusions. Intravenous PCA more effectively treats the pain of supratentorial intracranial surgery than PRN fentanyl, and patients in the former group did not experience any untoward events related to the self-administration of opioids. (DOI: 10.3171/2008.11.JNS08797)
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available